ETS-1 Expression Is Hypoxia-independent in Glioblastoma-derived Endothelial and Mesenchymal Stem-like Cells

被引:8
作者
Koessinger, Dominik [1 ,2 ]
Albrecht, Valerie [1 ]
Faber, Florian [1 ]
Jaehnert, Irene [1 ]
Schichor, Christian [1 ]
机构
[1] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Marchioninistr 15, D-81377 Munich, Germany
[2] Wuerzburg Univ Hosp, Dept Neurosurg, Wurzburg, Germany
关键词
ETS-1; primary glioblastoma; hypoxia; mesenchymal stem cell properties; tumor endothelial cells; TRANSCRIPTION FACTOR ETS-1; PLASMINOGEN-ACTIVATOR; GLIOMA-CELLS; INVASION; GROWTH; MIGRATION; SURVIVAL; MARKER;
D O I
10.21873/anticanres.12601
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Tumor cells infiltrating the brain are a typical hallmark of glioblastoma. Invasiveness of glioma cells has been associated with ETS proto-oncogene 1 (ETS-1). In non-glial tumors, ETS-1 expression has been linked to hypoxia. However, it is not known whether hypoxia regulates ETS-1 expression in glioblastoma. Materials and Methods: The spatial distribution of ETS-1 expression in primary glioblastoma was assessed using immunohistochemistry. ETS-1 expression in glioblastoma-derived mesenchymal stem-like cells (gbMSLCs) was determined using immunocytochemistry. The effect of hypoxia on ETS-1 expression of gbMSLCs, glioma cell lines and glioblastoma-derived endothelial cells was assessed using polymerase chain reaction and immunoblotting. Results: Our immunohistochemical studies revealed ETS-1 expression in stromal and endothelial glioblastoma cells. Stromal ETS-1 expression in glioblastoma correlated with microvessel density. gbMSLCs were found to express ETS-1. In all examined cell lines, ETS-1 transcription and expression were independent of hypoxia. Conclusion: In glioblastoma, ETS-1-expression is not dependent on hypoxia, but correlates with tumor vascularization.
引用
收藏
页码:3347 / 3355
页数:9
相关论文
共 27 条
[1]  
Anderson MK, 1999, DEVELOPMENT, V126, P3131
[2]   Glioma stem cells promote radioresistance by preferential activation of the DNA damage response [J].
Bao, Shideng ;
Wu, Qiulian ;
McLendon, Roger E. ;
Hao, Yueling ;
Shi, Qing ;
Hjelmeland, Anita B. ;
Dewhirst, Mark W. ;
Bigner, Darell D. ;
Rich, Jeremy N. .
NATURE, 2006, 444 (7120) :756-760
[3]   ETS-1 induces increased expression of erythroid markers in the pluripotent erythroleukemic cell lines K562 and HEL [J].
Clausen, PA ;
Athanasiou, M ;
Chen, Z ;
Dunn, KJ ;
Zhang, Q ;
Lautenberger, JA ;
Mavrothalassitis, G ;
Blair, DG .
LEUKEMIA, 1997, 11 (08) :1224-1233
[4]  
Davidson B, 2001, CLIN CANCER RES, V7, P551
[5]   The biology of the Ets1 proto-oncogene [J].
Jürgen Dittmer .
Molecular Cancer, 2 (1)
[6]   Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells [J].
Duda, DG ;
Sunamura, M ;
Lefter, LP ;
Furukawa, T ;
Yokoyama, T ;
Yatsuoka, T ;
Abe, T ;
Inoue, H ;
Motoi, F ;
Egawa, S ;
Matsuno, S ;
Horii, A .
ONCOGENE, 2003, 22 (44) :6857-6864
[7]   The expression of Wnt-inhibitor DKK1 (Dickkopf 1) is determined by intercellular crosstalk and hypoxia in human malignant gliomas [J].
Guo, Ke-Tai ;
Fu, Peng ;
Juerchott, Kathrin ;
Motaln, Helena ;
Selbig, Joachim ;
Lah, Tamara ;
Tonn, Joerg-Christian ;
Schichor, Christian .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2014, 140 (08) :1261-1270
[8]   The Transcription Factor ETS-1: Its Role in Tumour Development and Strategies for its Inhibition [J].
Hahne, Jens Claus ;
Okuducu, Ali Fuat ;
Sahin, Ayguen ;
Fafeur, Veronique ;
Kiriakidis, Serafim ;
Wernert, Nicolas .
MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2008, 8 (11) :1095-1105
[9]  
Iwasaka C, 1996, J CELL PHYSIOL, V169, P522, DOI 10.1002/(SICI)1097-4652(199612)169:3<522::AID-JCP12>3.0.CO
[10]  
2-7